Cargando…
Early phase clinical trials in oncology: realising the potential of seamless designs
BACKGROUND: The pharmaceutical industry’s productivity has been declining over the last two decades and high attrition rates and reduced regulatory approvals are being seen. The development of oncology drugs is particularly challenging with low rates of approval for novel treatments when compared wi...
Autores principales: | Jaki, Thomas, Burdon, Abigail, Chen, Xijin, Mozgunov, Pavel, Zheng, Haiyan, Baird, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614750/ https://www.ncbi.nlm.nih.gov/pubmed/37301716 http://dx.doi.org/10.1016/j.ejca.2023.05.005 |
Ejemplares similares
-
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
por: Mozgunov, Pavel, et al.
Publicado: (2019) -
An information theoretic phase I–II design for molecularly targeted agents that does not require an assumption of monotonicity
por: Mozgunov, Pavel, et al.
Publicado: (2018) -
Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology
por: Hobbs, Brian P, et al.
Publicado: (2018) -
Practical recommendations for implementing a Bayesian adaptive phase I design during a pandemic
por: Ewings, Sean, et al.
Publicado: (2022) -
An order restricted multi‐arm multi‐stage clinical trial design
por: Serra, Alessandra, et al.
Publicado: (2022)